3John A,Tuszynski G.The role of matrix metelloproteinases in tumorangiogenesis and tumor stasis[J].Pathol Res,2001 ;7(1):14-23.
4Fang J,Shing Y,Wiederschain D,et al.Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in[J].ProcNail Acad,2000; 97 (8):3884-3889.
5Sounni NE,Eievy L,Hajirou A,et al.MPI-MMP expression promotes tumor growth and angiogenes is through anuI regulation of vascular endothelial growth factor expression[J].Fasth,2002; 16(6):555-564.
6Deryugina El,Soroceanu L,Stmngin AY.Up-Regulation of Vascular Endothelial Growth Factor by Membrane-type Matrix Metalloproteinase Stimulates HumanGlioma Xenografet Growth and Angiogenesis[J].Cancer,2002:62(2):580-588.
7Naglich JG,Jure Kunkel M,Gupta E,et al.Trail Inhibition of Angicgenesis and Metastasis in Two Murine Models by the Matrix Metalloproteinase Inhibitor[J].Cancer Res,2001 ;61 (23):8480-8485.
9Ikenaka Y,Yoshi H,Kuriyamas,et al.Tissue inhibitor of metalloproteinase-1(TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1transgenic mouse model[J].Cancer,2003; 105 (3):340-346.
10Kleiner DE,Stetler-Stevenson WC.Matrix metallopteinases and metastasis[J].Cancer Chemother Pharmacol,1999;43(suppl):42-51.
二级参考文献38
1Ohashi K, Nemoto T, Nakamura K, et aL Increased expression of matrix metalloproteinase7 and 9 and membrane typel-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer,2000,88(10):2201-2209.
2Morgan AR,Zhang B,Tapper W,et al. Haplotypic analysis of the MMP9 gene in relation to coronary artery disease. J Mol Med,2003,81(5):321-326.
3Joos L, He JQ,Megan B,et al. The role of matrix metaloproteinase polymorphisrns in the rate of decline in lung function. Hum Mol Genet,2002,11(5):569-576.
4Kerkela E,Ala-Aho R, Jeskanen L,et al. Expression of human macrophage metalloelastase (MMP12) by tumor colls in skin cancer. J Invest Dermatol,2000,114(6):1113-1119.
5Ding Y, Shimada Y, Gorrin-Rivas MJ, et al. Clinicopathological significanco of human macrophage metalloelsstase expression in esophageal squamous cell carcinoma. Oncology,2002,63 (4):378-384.
6Szyllo K,Smolarz B,Romanowicz-Makowska H,et al. The promoter polymorphism of the matrix metalloproteinase3 (MMP3)gene in women with ovarian cancer. Exp Clin Cancer Res, 2002,21 (3):357-361.
7Liu PY,Chen JH,Li YH,et al. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost,2003,90(1):132-139.
8Ghilardi G,Biondi ML, Demonti M,et al. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke,2002,33 (10):2408-2412.
9Satsangi J,Chapman RW,Haldar N,et al. A functional polymorphism of the stromelysin gene (MMP3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology, 2001,121(1):124-130.
10Knox JD,Boreham DR,Walker JA,et al .Mapping of the metalloproteinase gene matrilysin(MMP7)to human chromosome11q21-q22. Cytogen Cell Genet, 1996, 72(2-3):179-182.
